Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis.
Schneider
Stefan W
SW
Staender
Sonja
S
Schlüter
Bernhard
B
Luger
Thomas A
TA
Bonsmann
Gisela
G
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000473:pathology; D008875:Middle Aged; D012867:Skin / Q000473:pathology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab